CGC

Canopy Growth
NYSE

Real-time Quotes | Nasdaq Last Sale

14.60
-1.44
-8.98%
After Hours: 14.61 +0.01 +0.07% 19:59 09/23 EDT
OPEN
15.90
PREV CLOSE
16.04
HIGH
16.02
LOW
14.28
VOLUME
9.45M
TURNOVER
--
52 WEEK HIGH
26.05
52 WEEK LOW
9.00
MARKET CAP
5.42B
P/E (TTM)
-3.7110
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
Are Marijuana Stocks Buys As Analyst Pleads 'Stop Growing So Much Weed'?
Investor's Business Daily · 3h ago
Are Marijuana Stocks Buys As Analyst Pleads 'Stop Growing So Much Weed'?
Investor's Business Daily · 4h ago
Aurora Falls 30%. ‘Please Stop Growing So Much Weed.’
“Aurora grows more stuff that people don’t want than they grow stuff people want,” analyst Bill Kirk wrote.
marketwatch.com · 5h ago
Aurora Cannabis Stock Plunged 30% Because It Is ‘Growing So Much Weed’
“Aurora grows more stuff that people don’t want than they grow stuff people want,” analyst Bill Kirk wrote.
Barrons.com · 5h ago
The Rise Of The Cannabis Industry – But What About Its Players?
Despite the pandemic, cannabis sales have continued to expand. Statistics Canada reported that in June, retail sales topped CA$ 201 million. This figure marks an 8% increase from May's total sales. During the second quarter of the year, the legal Canadian market finally exceeded the black market in revenue for the first time since marijuana was legalized in Canada in 2018.
Benzinga · 10h ago
Pot Takes a Hit as Aurora Cannabis Forecasts Weak Quarter
Shares are down 79% in 2020. Rivals also fell on the news, with Canopy Growth (NYSE:CGC) down 10%, Aphria (NASDAQ:APHA) lower by 3% and Cronos decreasing by almost 6%.
Investing.com · 10h ago
Marijuana Stocks: Aurora Cannabis Earnings Due As New CEO Steps In
Investor's Business Daily · 1d ago
Marijuana Stocks: Aurora Cannabis Earnings Due As New CEO Steps In
Investor's Business Daily · 1d ago
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of CGC. Analyze the recent business situations of Canopy Growth through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 10 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average CGC stock price target is 21.97 with a high estimate of 24.62 and a low estimate of 15.36.
EPS
Institutional Holdings
Institutions: 0
Institutional Holdings: 0
% Owned: 0.00%
Shares Outstanding: 371.30M
TypeInstitutionsShares
Increased
0
0
New
0
0
Decreased
0
0
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Pharmaceuticals
-0.52%
Pharmaceuticals & Medical Research
-1.14%
Key Executives
Chairman/Independent Director
Judy Schmeling
President
Rade Kovacevic
Chief Executive Officer/Director
David Klein
Chief Financial Officer/Executive Vice President
Mike Lee
Senior Vice President
Thomas Shipley
Vice President/IR Contact Officer
Judy Hong
Chief Accounting Officer/Vice President
Thomas Stewart
Other
Phillip Shaer
Director
Jimes Sabia
Independent Director
Robert Hanson
Independent Director
David Lazzarato
Independent Director
William Newlands
Director
Terry Yanofsky
Independent Director
Theresa Yanofsky
  • Dividends
  • Splits
  • Insider Activity
No Data
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About CGC
Canopy Growth Corp, formerly Tweed Marijuana Inc, is a Canada-based multi-brand cannabis company. The Company, through its subsidiaries Tweed Inc, Bedrocan Canada Inc, Tweed Farms Inc and Mettrum Health Corp is engaged in the business of producing and selling legal marijuana in the Canadian medical market. It is also focusing on producing and selling marijuana in the recreational market in Canada. Its core brands are Tweed and Bedrocan. Tweed is a licensed producer of medical marijuana. Tweed's commercial license covers approximately 168,000 square feet of its Smiths Falls facility and allows Tweed to produce and sell approximately 3,540 kilograms of medical marijuana per year. Tweed's built-out production capacity is over 10 climate controlled indoor growing rooms. Bedrocan is a medical-grade cannabis. Bedrocan's over 52,000 square feet production facility in Toronto, Ontario is licensed, and includes over 30 vegetative and growing rooms, and over three dispensing rooms.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of Canopy Growth Corp stock information, including NYSE:CGC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CGC stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading CGC stock methods without spending real money on the virtual paper trading platform.